APA (7th ed.) Citation

BK, F., V, K., HF, E., MK, T., SL, S., JS, P., . . . W, L. (2025). Compounds with dual glutaminase inhibition and Nrf2 activation activities enhance morphine analgesia and reduce pain sensitization in chemotherapy-induced peripheral neuropathy mouse model. The Journal of pharmacology and experimental therapeutics, 392(6), 103583. https://doi.org/10.1016/j.jpet.2025.103583

Chicago Style (17th ed.) Citation

BK, Foster, et al. "Compounds with Dual Glutaminase Inhibition and Nrf2 Activation Activities Enhance Morphine Analgesia and Reduce Pain Sensitization in Chemotherapy-induced Peripheral Neuropathy Mouse Model." The Journal of Pharmacology and Experimental Therapeutics 392, no. 6 (2025): 103583. https://doi.org/10.1016/j.jpet.2025.103583.

MLA (9th ed.) Citation

BK, Foster, et al. "Compounds with Dual Glutaminase Inhibition and Nrf2 Activation Activities Enhance Morphine Analgesia and Reduce Pain Sensitization in Chemotherapy-induced Peripheral Neuropathy Mouse Model." The Journal of Pharmacology and Experimental Therapeutics, vol. 392, no. 6, 2025, p. 103583, https://doi.org/10.1016/j.jpet.2025.103583.